Thienopyrimidines make an important class of heterocyclic compounds, which have attracted a great deal of attention due to their wide range of chemotherapeutic activities, including antimicrobial (1) (2) (3) (4) , moderate activity against tumor cell proliferation in vitro (5) (6) (7) , antiviral (8, 9) , analgesic and anti-inflammatory (10) (11) (12) (13) , antihistaminic (14) and anticonvulsant activities (15) . With a variety of derivatives obtained by annulations and functional group manipulations, many thieno[3,2-d]-pyrimidine derivatives occupy a special place because of their biological activities such as kinase (16) (17) (18) and phosphodiesterase IV inhibiting (19, 20) , gastric antisecretory (21) and antifolating (22) ones. Furthermore, several pyridone and imino pyridine derivatives are of chemotherapeutic importance (23) .
The combinations of thieno [3,2-d] pyrimidines with a variety of sulfa drugs and heterocycles might add a new biological, antibacterial and antifungal action. To the best of our knowledge, antibacterial and antifungal activity of thieno [3,2-d] pyrimidines has not been reported before.
EXPERIMENTAL
All melting points were taken on an Electrothermal IA 9100 series digital melting point apparatus (Shimadzu, Japan). Microanalytical data were obtained with the aid of a Vario Ele mentar Apparatus (Shimadzu). Elemental analyses of all compounds were within ± 0.4 % of the theoretical values (Table I ). The IR spectra (KBr) were recorded on a Perkin-Elmer 1650 spectrometer (Perkin-Elmer, USA). The 1 H and 13 C NMR spectra were measured with a Jeol ECA 500 MHz instrument (Jeol, Japan) in DMSO-d 6 and chemical shifts were recorded in d ppm relative to TMS. Mass spectra (EI) were run at 70 eV with a Finnigan SSQ 7000 spectrometer (Thermo-Instrument System Incorporation, USA). Purity of the compounds was checked on aluminium plates coated with silica gel (Merck, Germany).
3-Amino-5-(4-chlorophenyl)-thiophene-2-carboxylic acid, p-amino-acetophenone, ciprofloxacin and ketoconazole were obtained from Sigma-Aldrich (USA). Chemicals and solvents (Analar ≥ 99 %) were purchased from Sigma-Aldrich. [3,2-d] [1, 3] oxazin]-4¢(1¢H)-one (1) . -The compound was obtained from 3-amino-5-(4-chlorophenyl)thiophene-2-carboxylic acid (2.54 g, 0.01 mol) and cyclohexanone (1.24 g, 0.01 mol) refluxed in basic medium (ethanol and piperidine). The solid that separated upon cooling was filtered off in the form of white crystals.
Syntheses

6¢-(4-Chlorophenyl)-spiro[cyclohexane-1,2¢-thieno
Spiro[cyclohexane-1,2¢-thieno[3,2-d]pyrimidin]-3¢-yl]benzenesulfonamides (2a-e). General
procedure. -A mixture of 1 (3.33 g, 0.01 mol) and 0.01 mol of the appropriate sulfa drug (sulfanilamide, sulfaguanidine, sulfadiazine, sulfapyridine, sulfamethoxazole) in 20 mL glacial acetic acid containing anhydrous sodium acetate (1.64 g, 0.02 mol) was refluxed for 20 h. Upon pouring on crushed ice/water, crystals were obtained, filtered, washed with water and recrystallized from a proper solvent to give 2a-e, respectively. The following compounds were prepared: 
3¢-(4-Acetylphenyl)-6¢-(4-chlorophenyl)-1¢H-spiro[cyclohexane-1,2¢-thieno[3,2-d]pyrimidine-4¢(3¢H)-one (3)
. -A mixture of 1 (3.33 g, 0.01 mol) and 4-aminoacetophenone (1.35 g, 0.01 mol) in glacial acetic acid (20 mL) was refluxed for 6 h in the presence of sodium acetate (1.64 g, 0.02 mol). The reaction product was poured onto ice/water and neutralized with diluted NaOH. The obtained product was filtered off and washed with water to give pale yellow crystals. carbothioamide (4a-c) . General procedure. -A mixture of 2a (2.44 g, 0.05 mol) and anhydrous potassium carbonate (1.38 g, 0.01 mol) in dry acetone (50 mL) was refluxed under continuous stirring for 1.5 h. While hot, a solution of the appropriate isothiocyanate derivative, namely, methylisothiocyanate, cyclohexyl-isothiocyanate and phenyl isothiocyanate (0. 75 mol), in dry acetone was added dropwise and refluxing was continued for a further 18 h. Excess acetone was removed under reduced pressure and the obtained solid residue was washed with water, filtered and recrystallized from the proper solvent to give 4a-c, respectively. The following compounds were prepared:
-({4-[6¢-(4-chlorophenyl)-4¢-oxo-1¢,4¢-dihydro-3¢H-spiro[cyclohexane-1,2¢-thieno[3,2-d] pyrimidin]-3¢-yl]phenyl}sulfonyl)-phenyl-carbothioamide (4c).
6-{4-[6¢-(4-Chlorophenyl)-4¢-oxo-1¢,4¢-dihydro-3¢H-spiro[cyclohexane-1,2¢-thieno[3,2-d]-pyri midin]-3¢-yl]phenyl}-2-imino-4-aryl-1,2-dihydropyridine-3-carbonitriles (5a-e). General proce-
dure. -A mixture of acetyl derivative 3 (4.51 g, 0.01 mol), malononitrile (0.66 g, 0.01 mol) and the appropriate aldehyde (0.01 mol), and ammonium acetate (6.16 g, 0.08 mol) in n-bu ta nol (50 mL) was heated under reflux for 8 h. The solid that separated upon cooling was filtered off, washed with water and recrystallized from the proper solvent to obtain 5a-e, respecti vely. The following compounds were prepared:
6-{4-[6¢-(4-Chlorophenyl)-4¢-oxo-1¢,4¢-dihydro-3¢H-spiro[cyclohexane-1,2¢-thieno-[3,2-d]-3¢-yl]-pyrimidin]-2-oxo-4-substituted aryl-1,2-dihydropyridine-3-carbonitriles (6a-e). General pro-
cedure. -A mixture of acetyl derivative 3 (4.51 g, 0.01 mol), ethyl cyanoacetate (1.13 g, 0.01 mol) and the appropriate aldehyde (0.01 mol), and ammonium acetate (6.16 g, 0.08 mol) in n-butanol (50 mL) was heated under reflux for 8 h. The solid that separated upon cooling was filtered off, washed with water, recrystallized from the proper solvent to give 6a-e, respectively. The following compounds were prepared: Clorophenyl)-3¢-{4-[(2Z)-3-substituted arylprop-2-enoyl]phenyl}-1¢H-spiro[cyclo hexa ne-1,2¢-thieno[3,2-d]pyrimidin]-4¢(3¢H)-ones (7a-e) . General procedure. -A mixture of acetyl derivative 3 (4.51 g, 0.01 mol) and the appropriate aldehyde (0.01 mol) in 5 % ethanolic sodium hydroxide solution (40 mL) was refluxed under stirring for 18 h. The reaction mixture was poured onto ice/cold water and neutralized with dil. HCl. The formed precipitate was filtered off and recrystallized from the proper solvent to give 7a-e, respectively. The following compounds were prepared:
6¢-(4-
6¢-(4-clorophenyl)-3¢-{4-[(2Z)-3-phenylprop-2-enoyl]phenyl}- 1¢H-spiro[cyclohexane-1,2¢-thieno[3,2-d]pyrimidin]-4¢(3¢H)-one (7a), 6¢-(4-clorophenyl)-3¢- {4-[(2Z)-3-(4-chlorophenyl)-prop-2-enoyl]phenyl}-1¢H-spiro[cyclohexane-1,2¢-thieno[3,2-d] pyrimidin]-4¢(3¢H)-one (7b), 6¢-(4-clorophenyl)-3¢-{4-[(2Z)-3-(4-florophenyl)prop-2-enoyl] phenyl}-1¢H-spiro[cyclohexane-1,2¢-thieno[3,2-d]pyrimidin]-4¢(3¢H)-one (7c), 6¢-(4-cloro phenyl) -3¢-(4-{(2Z)-3-[4-(dimethylamino)-phenyl]prop-2-enoyl]-phenyl}-1¢H-spiro-[cyclohexane-1,2¢- thieno[3,2-d]pyrimidin]-4¢(3¢H)-one (7d), 6¢-(4-clo ro phenyl)-3¢-(4-[(2Z)-3-[2-(thienyl)prop-2- enoyl]phenyl}-1¢H-spiro [cyclohexane-1,2¢-thieno[3,2-d]pyrimidin]-4¢(3¢H)-one (7e).
6¢-(4-Chlorophenyl)-3¢-[4-(5-substituted aryl-4,5-dihydro-1H-pyrazol-3-yl)phenyl]-1¢H-spiro-[cyclohexane-1,2¢-thieno[3,2-d]pyrimidin]-4¢(3¢H)-ones (8a-e).
General procedure. -A mixture of unsaturated ketone 7a-e (0.01 mol) and 98 % hydrazine hydrate in absolute ethanol (2 mL) was refluxed for 6 h. Upon cooling, white crystals were obtained, filtered off and recrystallized from the proper solvent to obtain 8a-e, respectively. The following compounds were prepared:
6¢-(4-Chlorophenyl)-3¢-[4-(5-substituted aryl-4,5-dihydroisoxazol-3-yl)phenyl]-1¢H-spi ro[cyclohexane-1,2¢-thieno[3,2-d]pyrimidin]-4¢(3¢H)-ones (9a-e).
General procedure. -A mixture of unsaturated ketone 7a-e (0.01 mol) and hydroxylamine hydrochloride (1.38 g, 0.02 mol) in sodium hydroxide solution (0.5 g NaOH in 0.5 mL water) in ethanol (60 mL) was refluxed for 3 h. The product obtained upon cooling was filtered off, washed with water and recrystallized from the proper solvent to obtain the desired 9a-e, respectively. The following compounds were prepared: 6¢- 
6¢-(4-Chlorophenyl)-3¢-[4-(6-aryl(substituted)-2-thioxo-1,2-dihydropyrimidin-4-yl)-phenyl]-1¢H-spiro[cyclohexane-1,2¢-thieno-[3,2-d]pyrimidin]-4¢(3¢H)-ones (10a-e).
General procedure. -A mixture of unsaturated ketone 7a-e (0.01 mol), thiourea (0.01 mol) and sodium hydroxide (0.1 g) in absolute ethanol (30 mL) was refluxed for 6 h. The reaction mixture was concentrated under vacuum, cooled and neutralized with dilute HCl. The formed product was filtered off and washed with water to yield 10a-e, respectively. The following compounds were prepared: 6¢-(4-chlorophenyl)-3¢- [4-(6- compounds were dissolved in dimethylsulfoxide (DMSO) and tested for antimicrobial activity by the agar disk diffusion technique (24) , taking ciprofloxacin (25) and ketoconazole (26) as reference drugs for bacteria and fungi, respectively. A solution of 100 µg mL -1 of the test compound was applied and microplate-wells, 1 cm in diameter, were used. Zones of inhibition were measured with calipers or automated scanners and were compared with those of the standards. Ciprofloxacin (0.15 µmol mL ) were used as reference drugs for antibacterial and antifungal activity, respectively. Compound-impregnated disks were placed on an agar plate containing a standard suspension of microorganisms. The plate was incubated for 24 h at 37 °C.
For evaluation of minimum inhibitory concentration (MIC) by the serial plate dilution method (27) , 5 mg of each test compounds were dissolved in 1 mL of DMSO separately to prepare stock solutions. Serial dilutions were prepared from each stock solution. The plates were incubated at 37 °C for 24 h. MIC is defined as the lowest concentration (µmol mL -1 ) of the test compound that results in no visible growth on the plates. DMSO was used as a solvent control to ensure that the solvent had no effect on bacterial growth. The results are summarized in Tables III and IV . RESULTS 
AND DISCUSSION
Chemistry
The first step of our strategy was focused on ring transformation of oxazin to thieno [3,2- Refluxing compound 3 with the appropriate aldehyde and malononitrile or ethyl cyanoacetate in the presence of excess ammonium acetate in n-butanol afforded the corresponding aminopyridine 5a-e and pyridone derivatives 6a-e, respectively. Also, treatment of acetyl derivative 3 with appropriate aldehydes in 5 % ethanolic sodium hydroxide solution, afforded the corresponding α,β-unsaturated ketones 7a-e in moderate yields (Scheme 3). The 1 H NMR spectra of compounds 5, 6 and 7 revealed absorption bands of five (CH 2 -) methylene groups as multiplet absorption signals of the cyclohexane ring around d 2.46-3.01 ppm (Table II) .
α,β-unsaturated ketone is a simple substrate to synthesize a variety of heterocycles of known biological interest. Cyclocondensation of compounds 7a-e with N-nucleophiles under appropriate experimental conditions afforded pyrazoline derivatives 8a-e, isoxazolines 9a-e and thiopyrimidine derivatives 10a-e (Scheme 4).
Postulated structures of the newly synthesized compounds 8, 9 and 10 are in agreement with their IR, NMR spectral and elemental analysis data (Tables I, II 
